Active Recombinant Human VTN

Source :	Mammalian cells
Species :	Human
Predicted N Terminal :	Asp20
Form :	Lyophilized from a 0.2 µm filtered solution in Tris and NaCl.
Bio-activity :	Measured by the ability of the immobilized protein to support the adhesion of B16-F1 mouse melanoma cells.When 5 x 10^4 cells/well are added to Vitronectin coated plates (5 µg/mL with 100 µL/well), approximately >55% will adhere after 30 minutes at 37 °C. Optimal concentration depends on cell type as well as the application or research objectives..
Molecular Mass :	Recombinant Human VTN has a calculated MW of 52.3 kDa. In SDS-PAGE migrates as 70-80 kDa, reducing conditions.
Purity :	>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Storage :	Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Tag :	Non
Protein length :	20-478 a.a.

Gene Name	VTN vitronectin [ Homo sapiens ]
Official Symbol	VTN
Synonyms	VTN; vitronectin; vitronectin (serum spreading factor, somatomedin B, complement S protein); complement S protein; serum spreading factor; somatomedin B; VN; epibolin; S-protein; complement S-protein; serum-spreading factor; V75; VNT;
Gene ID	7448
mRNA Refseq	NM_000638
Protein Refseq	NP_000629
MIM	193190
UniProt ID	P04004
Chromosome Location	17q11.2